Formulation and evaluation of press coated tablets of esomeprazole for colonic delivery

Dhruv Malik, Inderbir Singh

Abstract


The present study was aimed to formulate press‐coated tablets of esomperazole magnesium trihydrate for colon specific delivery. Press coated tablets were formulated with an aim to prevent the gastric degradation of drug so as to improve the bioavailability of drug.Various polymers such as pH‐dependent (Eudragit L100, Eudragit S100), enzyme‐dependent (Pectin),and time‐dependent (HPMC K4M) were selected for press coating the drug‐incorporated core tablets. Fourier Transform Infrared (FTIR) analysis was performed to check the compatibility of drug and polymers. Core and coating materials were
evaluated for pre‐compression parameters like bulk density, tapped density, angle of repose, carrs index, and hausner’s ratio.Press coated tablets were evaluated for hardness, thickness, friability, tensile strength, drug content, and in vitro drug release. In vitro release studies were performed for 24 hours, first 2 hours in 0.1 N HCl, 3 hours in phosphate buffer (pH 6.8), and then for 19 hours in phosphate buffer (pH 7.4). In vitro drug release studies revealed that the tablets coated with pH‐dependent,enzyme‐dependent, and time‐dependent polymers showed no drug release in 0.1 N HCl, except for tablets coated with Pectin (25% and 50%, w/w). Kinetic modeling showed that the release exponent (n) value for all formulations was >0.89,indicating super case II transport to be the drug release mechanism. Press coated tablets for colonic delivery of esomeprazole
magnesium trihydrate were successfully developed.


Full Text:

PDF

References


Philip AK, Dabas S, Pathak K. Optimized prodrug approach: A means

for achieving enhanced anti‐inflammatory potential in experimentally

induced colitis. J Drug Target 2009;17:235‐41.

Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted

drug delivery systems. J Pharm Sci 2003;6:33‐66.

Watts PJ, Illum L. Colonic drug delivery. Drug Dev Ind Pharm

;23:893‐13.

Kinget R, Kalala W, Vervoort L, van den Mooter G. Colonic drug

targeting. J Drug Target 1998;6:129‐49.

Sinha VR, Kumria R. Polysaccharides in colon specific drug delivery:

A review. Int J Pharm 2001;224:19‐38.

Sirkiä T, Salonen H, Veski P, Jürjenson H, Marvola M. Biopharmaceutical

evaluation of new prolonged‐release press‐coated ibuprofen tablets

containing sodium alginate to adjust drug release. Int J Pharm

;107:179‐87.

Ozeki Y, Ando M, Watanabe Y, Danjo K. Evaluation of novel one‐step

dry coated tablets as a platform for delayed release tablets. J Control

Release 2004;1:51‐60.

Johnson DA. Review of esomeprazole in the treatment of acid disorders.

Expert Opin Pharmacotherapy 2003;4:253‐64.

Brunton LL, Lazo JS, Parker KL. Goodman and Gilman’s The

Pharmacological Basis of Therapeutics. New York: McGraw Hill; 2006.

Higuchi T. Mechanism of sustained‐action medication. Theoretical

analysis of rate of release of solid drugs dispersed in solid matrices.

J Pharm Sci 1963;52:1145‐9.

Hixson AW, Crowell JH. Dependence of reaction velocity upon

surface and agitation (I) theoretical consideration. Ind Eng Chem

;23:923‐31.

Korsmeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. Mechanism

of solute release from porous hydrophilic polymers. Int J Pharm

;15:25‐35.

Soad AY, Ahmed HE, Ibrahim S, Ahmed HS. Optimization of

budesonide compression‐coated tablets for colonic delivery. AAPS

Pharm Sci Tech 2009;10:147‐57.

Ashford M, Fell J, Attwood D. Studies on pectin formulations for

colonic drug delivery. J Control Rel 1994;30:225‐32.

Turkoglu M, Ugurlu T. In vitro evaluation of pectin‐HPMC compression

coated 5‐aminosalicylic acid tablets for colonic delivery. Eur J Pharm

Biopharm 2002;53:65‐73.




DOI: http://dx.doi.org/10.22377/ajp.v6i4.43

Refbacks

  • There are currently no refbacks.